Daniela Petrassi

Daniela Petrassi possesses extensive experience in the pharmaceutical industry, particularly in managing and developing hepatitis C virus (HCV) therapies. Held various leadership roles at AbbVie from January 2019 to April 2021, including HCV Therapy Development Manager, where responsibilities included leading a dedicated Infield Team to achieve HCV elimination objectives. Prior positions at AbbVie encompassed HCV Business Unit Manager and Brand Team Leader roles, as well as Brand Manager for Rheumatology. Daniela's earlier career at Abbott involved roles such as HCV Senior Brand Manager and Product Manager across multiple therapeutic areas including Rheumatology and Nephrology. Daniela holds a business degree from LUISS Business School, completed in 2010.